small molecule

DATSCAN

IOFLUPANE I-123

Loss of exclusivity—loss of exclusivity
CompanyGE HEALTHCARE INC

Drug detail

Brand nameDATSCAN
Active ingredientIOFLUPANE I-123
Strength5mCi/2.5ML (2mCi/ML)
Dosage formSOLUTION
RouteINTRAVENOUS
ModalitySmall molecule
FDA approvalJanuary 2011
Marketing statusRX

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.